John Giannaras

612 total citations
9 papers, 517 citations indexed

About

John Giannaras is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, John Giannaras has authored 9 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in John Giannaras's work include Inflammatory mediators and NSAID effects (4 papers), Estrogen and related hormone effects (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). John Giannaras is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Estrogen and related hormone effects (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). John Giannaras collaborates with scholars based in United States. John Giannaras's co-authors include Robert A. Copeland, Jean Williams, Donald Pinto, J M Trzaskos, Stephanie Pick, M Covington, Sherrill Nurnberg, Carl P. Decicco, Janet S. Kerr and Bruce Jaffee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

John Giannaras

9 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Giannaras United States	7	264	173	142	119	70	9	517
Sherrill Nurnberg United States	5	286 1.1×	229 1.3×	162 1.1×	114 1.0×	74 1.1×	7	661
W Galbraith United States	14	272 1.0×	277 1.6×	255 1.8×	116 1.0×	69 1.0×	24	833
Diana Kazanov Israel	14	241 0.9×	374 2.2×	78 0.5×	100 0.8×	22 0.3×	28	812
Shengrong Li China	15	85 0.3×	344 2.0×	125 0.9×	48 0.4×	42 0.6×	58	597
Jian‐Guo Tang China	13	177 0.7×	326 1.9×	182 1.3×	45 0.4×	21 0.3×	41	633
Yulia Maxuitenko United States	16	143 0.5×	479 2.8×	122 0.9×	63 0.5×	50 0.7×	46	775
J L Currie United States	7	117 0.4×	132 0.8×	145 1.0×	35 0.3×	20 0.3×	10	529
Tsung-Ying Shen United States	9	94 0.4×	208 1.2×	114 0.8×	34 0.3×	55 0.8×	12	542
João F. S. Carvalho Portugal	9	59 0.2×	287 1.7×	182 1.3×	62 0.5×	29 0.4×	12	522
Peter P.K. Ho United States	14	116 0.4×	331 1.9×	101 0.7×	42 0.4×	76 1.1×	26	612

Countries citing papers authored by John Giannaras

Since Specialization

Citations

This map shows the geographic impact of John Giannaras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Giannaras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Giannaras more than expected).

Fields of papers citing papers by John Giannaras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Giannaras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Giannaras. The network helps show where John Giannaras may publish in the future.

Co-authorship network of co-authors of John Giannaras

This figure shows the co-authorship network connecting the top 25 collaborators of John Giannaras. A scholar is included among the top collaborators of John Giannaras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Giannaras. John Giannaras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

George, Henry J., Kathleen Murphy, Randine L. Dowling, et al.. (1997). Recombinant Human 92-kDa Type IV Collagenase/Gelatinase from Baculovirus-Infected Insect Cells: Expression, Purification, and Characterization. Protein Expression and Purification. 10(1). 154–161. 16 indexed citations

Wright, Stephen W., Joseph J. Petraitis, Bruce Freimark, et al.. (1996). 2,5-Diarylisothiazolone: novel inhibitors of cytokine-induced cartilage destruction. Bioorganic & Medicinal Chemistry. 4(6). 851–858. 12 indexed citations

Rider, Nicholas L., Donald Pinto, Maryanne Covington, et al.. (1996). Comparative Effects of Selective Cyclooxygenase 1 and Cyclooxygenase 2 Inhibitors on Myeloperoxidase and 3α-Hydroxysteroid Dehydrogenase. Journal of enzyme inhibition. 10(2). 73–79. 2 indexed citations

Wright, Stephen W., Joseph J. Petraitis, Douglas G. Batt, et al.. (1995). Metabolism resistant isothiazolone inhibitors of cartilage breakdown. Bioorganic & Medicinal Chemistry. 3(3). 227–234. 10 indexed citations

Copeland, Robert A., et al.. (1995). Estimating KI values for tight binding inhibitors from dose-response plots. Bioorganic & Medicinal Chemistry Letters. 5(17). 1947–1952. 90 indexed citations

Copeland, Robert A., Jean Williams, John Giannaras, et al.. (1994). Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.. Proceedings of the National Academy of Sciences. 91(23). 11202–11206. 338 indexed citations

Giannaras, John, et al.. (1990). Characterization of extracellular phospholipase A2 (PLA2) activity in fluid and peritoneal cells from casein-treated rats. Inflammation. 14(4). 389–399. 3 indexed citations

Jaffee, Bruce, et al.. (1989). The effect of immunomodulating drugs on adjuvant-induced arthritis in Lewis rats. Inflammation Research. 27(3-4). 344–346. 32 indexed citations

Chin, Jia En, et al.. (1989). Phospholipase A2 (PLA2) activity in rabbit chondrocytes. Inflammation Research. 27(3-4). 385–387. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact